Your Representative needs to hear from you about the importance of stem cell research in the fight to Stop Diabetes. Tell your legislator that you support H.R. 2433, the Stem Cell Research Advancement Act of 2013, a bill that sets strict ethical guidelines for human embryonic stem cell research while ensuring the continuation of federal funding for these studies at the National Institutes of Health. Tell your Representative to cosponsor H.R. 2433 today!
Please take a moment to personalize your letter to explain the
impact diabetes has had on your life. Stories always make a better case
than statistics, and personalized e-mails will have an even greater
impact than form e-mails. Personalizing your letter is extremely important!
By providing your mobile phone number you are opting in to receive mobile updates from the American Diabetes Association. Standard data and message rates apply.
Dear [Decision Maker],
As a constituent who is very concerned about the impact of diabetes on our citizens, I stand with the American Diabetes Association (Association) in urging you to support stem cell research by cosponsoring H.R. 2433, the Stem Cell Research Advancement Act of 2013. Scientists in the United States and throughout the world believe human embryonic stem cell research, holds great promise in the search for a cure for diabetes and, until then, as a powerful tool for controlling this terrible disease. With this in mind, the Association was pleased President Obama issued an Executive Order in 2009 expanding federal funding of human embryonic stem cell research at the National Institutes of Health (NIH) followed the Executive Order by establishing strict ethical guidelines for this research. While the Executive Order significantly broadened opportunities for stem cell research, it is not set in federal statute. Legislation is needed to codify these guidelines in federal law to ensure this important avenue of research remains open. Fortunately, H.R. 2433 provides for the continuation of human embryonic stem cell research by allowing additional stem cell lines to be eligible for federal funding regardless of the date they were derived. The legislation codifies the Executive Order and the NIH guidelines.
Sincerely,[Your Name] [Your Address] [City, State ZIP]